Regulatory Affairs
Home/Services/Regulatory Affairs

Regulatory Affairs

VCRO offers precise, up-to-date and comprehensive regulatory services to help our clients meeting development and registration objectives.

Regulatory Affairs (RA) Team within VCRO offers a wide spectrum of regulatory services covers IND to NDA/BLA for new drugs, device, and combinational product. We can be a professional regulatory consultant for our clients, guiding the development and registration strategy from authority’s point of view, alone with integrating multiple countries’ regulatory requirements to form the most efficient plan. We can also be our clients’ best resource in executing tedious and sophisticated regulatory procedures which require high level of accuracy and precision. Apart from all technical strengths and decades of experiences accumulated within VCRO, maintaining smooth communications and growing mutual trusts with health authorities are particular critical values that VCRO’s RA team can benefit our clients in terms of accelerating regulatory procedures.

VCRO RA services to be applied to the US and Taiwan:

  • Regulatory consultation service
  • Regulatory consultation meeting service
Dossier preparations, compiling, submission, management of review procedures for:

 

  • Clinical trial (for health authority and IRB/IEC)
  • Investigational New Drug (IND) (CTD, eCTD, traditional)
  • New Drug Application (NDA) (CTD, eCTD)
  • Plant Master File (PMF)
  • Medical device product registration
  • Medical device GMP/QSD
  • Bridging study evaluation report
  • Clinical trial interim report
舞狮争霸走势图 微乐吉林麻将游戏 安卓 贵州11选5 天天彩选四预测 能够赚钱的网页游戏 甘肃快3正文一定牛 山东十一选五软件 金宝博188比分 大龙地产股票最新消 哪个平台有澳洲幸运8 正规网上兼职赚钱 安徽快3时时彩投注 期期公开验证十码 大地棋牌 捕鱼来了弹头多少钱 南京麻将100 怎么看平特一肖规律